Purpose: The objective of the current study was to explore the role of CHA2DS2-VASc
score in predicting incidence of atrial fibrillation (AF) in patients with type 2
diabetes mellitus (DM). Furthermore, the use of the CHA2DS2-VASc score for stratifying
new-onset AF risk in patients with DM and with/without hyperosmolar hyperglycaemic
state (HHS) was also compared.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Metabolism - Clinical and ExperimentalAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
